Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2012
10/18/2012US20120264757 Composition and Method for Treating Hemorrhoids and/or Anorectal Disorders
10/18/2012US20120264691 Medical compositions containing ghrelin
10/18/2012US20120264676 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
10/18/2012US20120263812 Use of an extract of punica granatum for combating canities
10/18/2012US20120263702 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis
10/18/2012US20120263686 Compositions and improved soft tissue replacement methods
10/18/2012DE102011007272A1 Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung Branched 3-phenylpropionic acid derivatives and their use
10/18/2012CA2832650A1 Novel pyrazole derivative
10/18/2012CA2826188A1 Aclidinium for use in improving the quality of sleep in respiratory patients
10/17/2012EP2511371A1 Anticancer anti-mortalin peptide antibodies
10/17/2012EP2511276A1 Pyrrolo[2,3-d]pyrimidine derivative
10/17/2012EP2511271A1 Heteroarylcarboxylic acid ester derivative
10/17/2012EP2511269A1 Fused heterocyclic compound having amino group
10/17/2012EP2511268A1 Oxazine derivative
10/17/2012EP2510948A1 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance
10/17/2012EP2510928A1 Aclidinium for use in improving the quality of sleep in respiratory patients
10/17/2012EP2510926A1 Use of saturated amines compounds in manufacture of medicaments for mobilizing peripheral blood hematopoietic stem cell
10/17/2012EP2509989A1 Sucrose octasulfates of zinc, the preparation of same and the pharmaceutical and cosmetic uses thereof
10/17/2012EP2509606A1 Novel medical use
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN102741410A Modulation of HSP47 expression
10/17/2012CN102741405A System for increasing gene expression, and vector supporting said system
10/17/2012CN102741256A Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase
10/17/2012CN102741243A Novel compound amycolatopsis derivative, and production process and use of same
10/17/2012CN102740886A Use of vap-1 inhibitors for treating fibrotic conditions
10/17/2012CN102740865A Mitochondrial function improver
10/17/2012CN102740860A Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
10/17/2012CN102731379A N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
10/17/2012CN102727585A Medicine for preventing food preference, picky eating habit, anorexia, manufacturing method and application method thereof
10/17/2012CN102727501A Uses of sapogenins and their derivatives
10/17/2012CN102727403A Chinese herbal medicinal toothpaste
10/17/2012CN102085344B Aplotaxis carminative sustained-release preparation and preparation method thereof
10/17/2012CN101939297B Benzylpiperizine compound
10/17/2012CN101880324B Monoclonal antibody of anti-human SIRPalpha, cell strain, preparation method and application thereof
10/17/2012CN101481380B Thiofuran pyridazine compound, preparation thereof, pharmaceutical composition and uses thereof
10/17/2012CN101223134B Derivatives of seleno-amino acids
10/16/2012US8288560 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
10/16/2012US8288539 Dipeptidyl peptidase inhibitors
10/16/2012US8288421 Phenylaminopyridines
10/16/2012US8288399 Medicine containing pyrimidine derivative
10/16/2012US8288368 inhibitors of the C5a induced chemotaxis; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, rheumatoid arthritis and in the prevention and the treatment of injury caused by ischemia and reperfusion
10/16/2012US8288139 Sulfotransferase inhibitors
10/16/2012US8287873 Vascular endothelial cell growth factor antagonists and uses thereof
10/16/2012CA2533753C Drug for cancer therapy
10/16/2012CA2485681C Ccr9 inhibitors and methods of use thereof
10/16/2012CA2466773C Inhibitor oligonucleotides and their use for specific repression of a gene
10/16/2012CA2446781C Coated granules based on angiotensin-converting enzyme inhibitor
10/16/2012CA2422865C Aminolevulinic acid photodynamic therapy for treating sebaceous gland disorders
10/16/2012CA2364300C A skin care composition that mediates cell to cell communication
10/16/2012CA2356257C Insulin-like growth factor (igf) i mutant variants
10/11/2012WO2012139119A1 Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same
10/11/2012WO2012138453A1 Efficient protein expression in vivo using modified rna (mod-rna)
10/11/2012WO2012138246A1 Pharmaceutical composition for treating hyperproliferative diseases
10/11/2012WO2012137967A1 Calcium phosphate microcapsule
10/11/2012WO2012137870A1 Novel imidazo-oxazine compound or salt thereof
10/11/2012WO2012137538A1 Cytotoxic t cell inducing composition
10/11/2012WO2012136699A1 Use of l-carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function
10/11/2012WO2012136694A1 Pyridopyrazine derivatives and their use
10/11/2012WO2012136691A1 Pyridopyrazine derivatives and their use
10/11/2012WO2012136224A2 Methods and compositions for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy
10/11/2012US20120259413 Devices, compositions and methods utilizing ep4 and ep2 receptor agonists for preventing, reducing or treating capsular contracture
10/11/2012US20120259093 Expression of secreted human alpha-fetoprotein in transgenic animals
10/11/2012US20120258962 1,3-oxazines as bace1 and/or bace2 inhibitors
10/11/2012US20120258169 Chewable Soft Capsule
10/11/2012US20120258070 Methods and Compositions for Promoting Organ Development
10/11/2012US20120258040 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
10/11/2012DE112009003659T5 Mittel zur Beseitigung einer Multiarzneimitelresistenz Means for removing a multidrug resistance Mitel
10/11/2012DE102011006974A1 New substituted 1-benzylcycloalkylcarboxylic acid compounds are soluble guanylate cyclase activators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertension, ischemia and vascular disease
10/11/2012DE102010051391A1 New lisuride, terguride or 1,1-diethyl-3-(R)-4,6,6a,7,8,9,10,10a-octa hydro-indolo(4,3-fg)quinolin-9-yl-urea derivative, is 5-hydroxytryptamine 2A receptor antagonist, useful to treat and/or prevent pulmonary arterial hypertension
10/11/2012CA2832337A1 Pyridopyrazine derivatives and their use
10/11/2012CA2832321A1 Pyridopyrazine derivatives and their use
10/11/2012CA2830367A1 Novel imidazo-oxazine compound or salt thereof
10/10/2012EP2508606A1 Partial fragment of REIC/Dkk-3 gene and therapeutic agent for cancer containing the same
10/10/2012EP2508603A1 System for increasing gene expression, and vector supporting said system
10/10/2012EP2508513A1 2-pyridone compounds
10/10/2012EP2508503A1 Spiro compounds and pharmaceutical use thereof
10/10/2012EP2508204A2 Remedies for diseases caused by vascular contraction or dilation
10/10/2012EP2508200A1 Carbonic anhydrase i serving as novel antigen to be used for treatment of autoimmune diseases
10/10/2012EP2508190A1 Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages
10/10/2012EP2508185A1 Anti-tumor effect potentiator
10/10/2012EP2508184A1 Pyridopyrazine derivatives and their use
10/10/2012EP2508179A1 Use of L-Carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function
10/10/2012CN1953968B Thiazole compound and use thereof
10/10/2012CN1662251B Adjuvant enhanced immunotherapy
10/10/2012CN1607957B Modulation of excitable tissue function by peripherally administered erythropoietin
10/10/2012CN1452496B Use of strains of parapox ovis virus against organ fibrosis
10/10/2012CN102725288A Method for manufacturing a 6-substituted-1-methyl-1H-benzimidazole derivative, and manufacturing intermediate from said method
10/10/2012CN102725287A 1,3,4-oxadiazole-2-carboxamide compound
10/10/2012CN102718870A Insulin bio-sensitizer and application thereof
10/10/2012CN102718730A Methods of synthesis and/or purification of diaminophenothiazinium compounds
10/10/2012CN102716473A Active immunoregulation method for fused prolactin proteins of goose eggs
10/10/2012CN102716388A Chinese herbal medicine composition for treating night cramp pain of feet and legs
10/10/2012CN102716365A TCM preparation for assisting in therapy of shivering and sweating and preparation method
10/10/2012CN102716363A Blighted wheat TCM preparation for curing sweat syndromes and preparation method
10/10/2012CN102716334A Chinese medicinal composition for dispelling the cold and removing stasis
10/10/2012CN102716329A Tortoise shell TCM preparation for curing sweat syndromes and preparation method
10/10/2012CN102716200A Method for concocting honey-fried bran white paeony root
10/10/2012CN102716088A Folate coupled chitosan ligustrazine nanoparticle preparation
10/10/2012CN102276683B Smilaxchinoside compound
10/10/2012CN102178910B Chinese medicine preparation for relieving symptoms of people with blood stasis, and preparation method and application thereof
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 1564